
Overview
Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care.
Dr. Lange is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy.
Her clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 17 articles in the study of Melanoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
Locations
601 North Caroline Street, Floor 8, Floor 8, Baltimore, MD 21287
201 North Broadway Street, Viragh BLDG 10th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Francesco Marincola is a Surgical Oncologist in Bethesda, Maryland. Dr. Marincola is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Breast Cancer, Colorectal Cancer, and Gliomatosis Cerebri.
The Johns Hopkins Hospital
Dr. Topalian is a physician-scientist whose studies of anti-tumor immunity have been foundational in developing cancer immunotherapy. She has published over 160 original research articles and reviews in this area and is one of the most highly cited researchers in the biomedical field. She received her medical and scientific training at Tufts University School of Medicine, Thomas Jefferson University Hospital, Children’s Hospital of Philadelphia and the National Cancer Institute. She joined the Johns Hopkins Kimmel Cancer Center in 2006 as the inaugural director of its Melanoma Program. Dr. Topalian is credited with advancing the clinical development of anti-PD-1 immunotherapy, and her work is widely recognized. She was named one of Nature’s 10 in 2014, and received the Karnofsky Award from ASCO in 2015, the Taubman Prize in 2016, the NCI’s Rosalind E. Franklin Award in 2018, the American Academy of Dermatology’s Gruber Memorial Cancer Research Award in 2020, and the Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2021 for landmark discoveries in cancer immunotherapy. Dr. Topalian was elected to the National Academy of Medicine in 2017, and to the American Association for Cancer Research Academy in 2022. Her work has opened new avenues of scientific investigation and established immunotherapy as a pillar of oncology. Dr. Topalian is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Anal Cancer.
Medstar Medical Group Ii LLC
Edward Mccarron is a General Surgeon and a Surgical Oncologist in Glen Burnie, Maryland. Dr. Mccarron is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Familial Pancreatic Cancer, Ogilvie Syndrome, Hernia Surgery, and Pancreatectomy. Dr. Mccarron is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Lange isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Lange isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Lange isDistinguished. Learn about Inflammatory Breast Cancer.
- MelanomaDr. Lange isDistinguished. Learn about Melanoma.
- Paget Disease of the BreastDr. Lange isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Eccrine PorocarcinomaDr. Lange isAdvanced. Learn about Eccrine Porocarcinoma.
- Intraductal PapillomaDr. Lange isAdvanced. Learn about Intraductal Papilloma.
- LymphadenectomyDr. Lange isAdvanced. Learn about Lymphadenectomy.
- LymphedemaDr. Lange isAdvanced. Learn about Lymphedema.
- Merkel Cell CarcinomaDr. Lange isAdvanced. Learn about Merkel Cell Carcinoma.
- Experienced
- FibroadenomaDr. Lange isExperienced. Learn about Fibroadenoma.
- GalactocoeleDr. Lange isExperienced. Learn about Galactocoele.
- Giant Mammary HamartomaDr. Lange isExperienced. Learn about Giant Mammary Hamartoma.
- LymphangiectasisDr. Lange isExperienced. Learn about Lymphangiectasis.
- Lymphofollicular HyperplasiaDr. Lange isExperienced. Learn about Lymphofollicular Hyperplasia.
- Meige DiseaseDr. Lange isExperienced. Learn about Meige Disease.

